29 Oct 2010 11:34
Instem Life Science Systems plc ('the Company')
29 October 2010
VOTING RIGHTS AND CAPITAL
In conformity with the Disclosure and Transparency Rules we would like to notify the market of the following:
The Company's issued share capital consists of 11,714,286 ordinary shares with a nominal value of 10p each ('Ordinary Shares'). The Company does not hold any Ordinary Shares in Treasury.
Therefore, the total number of voting rights in the Company is 11,714,286
The figure of 11,714,286 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FSA's Disclosure and Transparency Rules.
For further information, please contact:
Instem Life Science Systems plc | +44 (0) 1785 825600 |
Phil Reason, CEO | |
Jim McLauchlan, CFO | |
Brewin Dolphin - Financial Advisor, Broker & NOMAD | +44 (0) 0845 213 4730 |
Mark Brady | |
Sean Wyndham-Quin | |
Rickitt Mitchell - Joint Financial Advisor to the Company | +44 (0) 161 834 0600 |
Matthew Bryden-Smith | |
Neil Mitchell | |
Threadneedle Communications | +44 (0) 20 7653 9850 |
Caroline Evans-Jones | |
Fiona Conroy | |
Josh Royston |